http://annalsgastro.gr/index.php/annalsgastro/issue/feed Annals of Gastroenterology 2024-03-20T12:22:23+02:00 Annals of Gastroenterology annalsgastro@gmail.com Open Journal Systems http://annalsgastro.gr/index.php/annalsgastro/article/view/7227 Approach to esophageal absent contractility: can we do better? 2024-03-20T12:22:20+02:00 Amir Mari amir.mari@hotmail.com Sari Cohen sarico@post.bgu.ac.il Daniel L Cohen docdannycohen@yahoo.com Tawfik Khoury tawfikkhoury1@hotmail.com Fadi Abu Baker fa_fd@hotmail.com Wisam Abboud wisam_abbud@nazhosp.com Edoardo Vincenzo Savarino edoardosavarino@gmail.com Marcella Pesce mapesc@hotmail.com <p>Absent contractility (AC), a motility disorder characterized by the absence of esophageal contractions while maintaining normal lower esophageal sphincter relaxation, is recognized as a distinctive major disorder of peristalsis on esophageal high-resolution manometry that warrants comprehensive understanding. This unique motility disorder often co-occurs with connective tissue, rheumatologic or autoimmune diseases, with scleroderma being the classic example. Symptoms of gastroesophageal reflux are common. AC can profoundly impact patients’ lives and result in a spectrum of complications, including erosive esophagitis, esophageal candidiasis, Barrett’s esophagus, and malnutrition. To address the intricate complexities of AC and its multifaceted complications, a multidisciplinary approach is paramount. This approach considers the distinct clinical presentation and underlying rheumatologic conditions of the individual patient, recognizing the inherent diversity within this disorder. While medical management of gastroesophageal reflux remains the cornerstone of AC treatment, emerging surgical and endoscopic interventions offer additional therapeutic options for those grappling with this challenging condition. This comprehensive review provides an in-depth evaluation of recent<br>advances in our understanding of AC and its management. It endeavors to offer valuable insights into therapeutic strategies for AC and its associated issues.</p> <p><strong>Keywords</strong> Absent contractility, esophageal motility disorders, gastroesophageal reflux disease, diagnosis, management</p> <p>Ann Gastroenterol 2024; 37 (2): 117-124</p> 2024-03-14T17:56:33+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7053 Gut microbiota in celiac disease 2024-03-20T12:22:21+02:00 Nehal Yemula nehal_95@hotmail.com <p>Celiac disease (CD) is an autoimmune gastrointestinal disease triggered by dietary gluten, occurring in genetically predisposed individuals. Currently, a gluten-free diet is the only current evidenced-based treatment for CD. With the growing prevalence of this condition worldwide, adjuvant therapies are needed. We understand that there are several factors that influence the pathogenesis of the condition. There is a complex interplay between genetics, environmental triggers, the immune system and gut microbiota. Recently, there has been a growing focus on<br>the significance of gut microbiota in several autoimmune-based conditions. In particular, there has been much research involving the role of microbial flora and CD. Here, in this mini-review, we highlight the importance of gut microbiota and the symbiotic relationship with the host, introduce key factors that influence the development of the intestinal flora in early colonization, and ultimately explore its role in the pathogenesis of CD.</p> <p><strong>Keywords</strong> Gastrointestinal microbiota, celiac disease, gluten</p> <p>Ann Gastroenterol 2024; 37 (2): 125-132</p> 2024-03-19T09:09:43+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7205 Artificial intelligence in gastrointestinal endoscopy: a comprehensive review 2024-03-20T12:22:21+02:00 Hassam Ali alih20@ecu.edu Muhammad Ali Muzammil muzammil200077@gmail.com Dushyant Singh Dahiya dush.dahiya@gmail.com Farishta Ali ali.farishta@gmail.com Shafay Yasin shafayyasin@gmail.com Waqar Hanif waqarhanif75@gmail.com Manesh Kumar Gangwani gangwani.manesh@gmail.com Muhammad Aziz marajani@hotmail.com Muhammad Khalaf khalafm22@ecu.edu Debargha Basuli BASULID17@ECU.EDU Mohammad Al-Haddad moalhadd@iu.edu <p>Integrating artificial intelligence (AI) into gastrointestinal (GI) endoscopy heralds a significant leap forward in managing GI disorders. AI-enabled applications, such as computer-aided detection and computer-aided diagnosis, have significantly advanced GI endoscopy, improving early detection, diagnosis and personalized treatment planning. AI algorithms have shown promise in the analysis of endoscopic data, critical in conditions with traditionally low diagnostic sensitivity, such as indeterminate biliary strictures and pancreatic cancer. Convolutional neural networks can markedly improve the diagnostic process when integrated with cholangioscopy or endoscopic ultrasound, especially in the detection of malignant biliary strictures and cholangiocarcinoma. AI’s capacity to analyze complex image data and offer real-time feedback can streamline endoscopic procedures, reduce the need for invasive biopsies, and decrease associated adverse events. However, the clinical implementation of AI faces challenges, including data quality issues and the risk of overfitting, underscoring the need for further research and validation. As the technology matures, AI is poised to become an indispensable tool in the gastroenterologist’s arsenal, necessitating the integration of robust, validated AI applications into routine clinical practice. Despite remarkable advances, challenges such as operator-dependent accuracy and the need for intricate examinations persist. This review delves into the transformative role of AI in enhancing endoscopic diagnostic accuracy, particularly highlighting its utility in the early detection and personalized treatment of GI diseases.</p> <p><strong>Keywords</strong> Medical imaging, gastroenterology, artificial intelligence, machine learning, deep learning</p> <p>Ann Gastroenterol 2024; 37 (2): 133-141</p> 2024-03-19T09:13:45+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7159 Perioperative nutritional assessment and management of patients undergoing gastrointestinal surgery 2024-03-20T12:22:21+02:00 Aristea Gazouli agazouli@gmail.com Konstantinos Georgiou kongeorgiou@hotmail.com Maximos Frountzas froumax@hotmail.com Gerasimos Tsourouflis gerasimos.ts@gmail.com Nikola Boyanov marbact@hotmail.com Nikolaos Nikiteas nnikit@med.uoa.gr Maria Gazouli mgazouli@med.uoa.gr George E. Theodoropoulos georgetheocrs@live.com <p>Malnutrition is a major issue in gastrointestinal perioperative situations, as only 40% of malnourished patients are finally treated. This literature review investigates the inconsistencies regarding the diagnostic approach to both preoperative and postoperative patients and the various underlying causes, as well as the efficiency of the various therapeutic regimens. A literature search was conducted until August 2023 in MEDLINE and Scopus. Clinical studies involving perioperative nutritional assessment in adult gastrointestinal surgery patients during the last 10 years were included in the present review. Finally, 19 articles were included in the study. Preoperative nutritional therapy is increasingly recognized as a key component of surgical care. Malnourished patients who are hospitalized and operated on, have significantly worse clinical results. Gastrointestinal postoperative malnutrition coexists with metabolic stress, as patients usually suffer from minor chronic inflammations; therefore, postoperative malnutrition is the result of a combination of the effects of inflammation and a lack of food intake. Postoperative malnutrition leads to prolonged hospitalizations and hospital complications and therefore the need to treat it is essential. There are many recognized tools for detecting malnutrition. However, all tools showed inconsistent results regarding their validity. Per os feeding after surgery, and dietary supplements when necessary, have been recommended. Therefore, it is very important to reduce malnutrition and define clear strategies towards that direction.</p> <p><strong>Keywords</strong> Perioperative nutritional management, assessment, gastrointestinal, surgery</p> <p>Ann Gastroenterol 2024; 37 (2): 142-154</p> 2024-03-19T09:18:37+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7182 Efficacy of esophageal stents as a primary therapeutic option in spontaneous esophageal perforations: a systematic review and meta-analysis of observational studies 2024-03-20T12:22:21+02:00 Ioannis Margaris margaris87@gmail.com Tania Triantafyllou t_triantafilou@yahoo.com Theodoros A. Sidiropoulos theosidiropoulos@hotmail.com Giorgos Sideris siderisgior@gmail.com Dimitrios Theodorou dimitheod@netscape.net Nikolaos Arkadopoulos narkado@hotmail.com Nikolaos V. Michalopoulos nmichal@med.uoa.gr <p><strong>Background</strong> Spontaneous esophageal perforation traditionally mandates urgent surgical treatment. Lately, esophageal stents have been used to reduce the associated morbidity and mortality. The current systematic review aimed to assess the efficacy of stents as a primary treatment option in this scenario.</p> <p><strong>Methods</strong> A systematic search was conducted in PubMed/MEDLINE, Scopus and the Cochrane Library for studies published in the English language between 2000 and 2023. We included observational studies reporting on the use of stents, alongside conservative measures and drainage procedures, in patients with spontaneous esophageal perforations. Primary outcomes were sealing rate (persistent leak occlusion) and failure rate (mortality or conversion to a major surgical operation). Secondary outcomes included patients’ presentation, sepsis, drainage procedures, and reinterventions. Results for primary outcomes were presented as pooled rates with 95% confidence intervals (CIs), using a random-effects model. Methodological quality was assessed using the MINORS score.</p> <p><strong>Results</strong> Eighteen studies involving 171 patients were included. Sealing rate was 86% (95%CI 77- 93%) and failure rate was 14% (95%CI 7-22%). Weighted mortality rate was 6% (95%CI 2-13%), while conversion to surgical treatment was 2% (95%CI 0-9%). Late presentation was not related to a statistically significant increase in treatment failure (odds ratio 1.85, 95%CI 0.37-9.30; P=0.72). Drainage procedures were required for the majority of patients, with a high rate of surgical and endoscopic reinterventions.</p> <p><strong>Conclusions</strong> Our results imply that stents may offer an effective and safe alternative treatment for patients with spontaneous esophageal perforations. Additional endoscopic and surgical drainage procedures are frequently needed.</p> <p><strong>Keywords</strong> Boerhaave syndrome, spontaneous esophageal perforation, stent, esophagus, selfexpanding metal stent</p> <p>Ann Gastroenterol 2024; 37 (2): 156-171</p> 2024-03-19T10:06:34+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7267 Evaluation of parameters influencing the quality of colon preparation with a split-dose regimen of sulfate salts 2024-03-20T12:22:21+02:00 Alexandros Ioannou michosp5@gmail.com Georgios Axiaris michosp5@gmail.com Panagiotis Baxevanis michosp5@gmail.com Evgenia Papathanasiou michosp5@gmail.com Mary Tzakri michosp5@gmail.com Charalampos Koumentakis michosp5@gmail.com Pavlos Pardalis michosp5@gmail.com Emmanouil Pantelakis michosp5@gmail.com Larisa Vasilieva michosp5@gmail.com Georgios Leonidakis michosp5@gmail.com Evanthia Zampeli michosp5@gmail.com Spyridon Michopoulos michosp5@gmail.com <p><strong>Background</strong> Bowel cleansing is an important factor for the quality of colonoscopy. We aimed to evaluate the efficacy of split-dose oral sulfate salts on bowel preparation and to determine parameters influencing the quality of bowel cleaning.</p> <p><strong>Method</strong> Consecutive adults who completed their preparation for colonoscopy with a regimen of sulfate salts were enrolled.</p> <p><strong>Results</strong> Of the 446 patients, 11 were excluded from the analysis. Among the 435 patients, 257 (59.1%) were female, mean age was 62.0±11.6 years and median body mass index (BMI) 26.1 kg/m2 (interquartile range [IQR] 23.8-29.4). Indications for colonoscopy were screening 155 (35.6%), surveillance 102 (23.5%), or other 178 (40.9%). The median time between the end of second dose of the preparation regimen and colonoscopy initiation was 5:15 h (IQR 4:30-6:00, min: 2:20, max: 12:20). Minor adverse events were reported in 62 (14.3%) patients. BBPS=9 was observed in 279 (64.14%) patients. Segmental BBPS=3 was achieved in 387 (88.97%), 346 (79.54%) and 289 (66.44%) patients (P&lt;0.001) in the descending, transverse and ascending colon, respectively. Multivariate analysis revealed that BMI (odds ratio [OR] 1.05, 95% confidence interval [CI] 1-1.1) and time between the end of the second laxative dose and colonoscopy initiation (OR 1.25, 95%CI 1.08-1.45) were associated with poorer bowel<br>preparation.</p> <p><strong>Conclusions</strong> A split dose of oral sulfate salts is an efficacious and well tolerated regimen. Obesity and a longer time interval between the end of the second dose and colonoscopy initiation negatively influence bowel cleanliness.</p> <p><strong>Keywords</strong> Colonoscopy, bowel preparation, oral triphosphate</p> <p>Ann Gastroenterol 2024; 37 (2): 172-178</p> 2024-03-19T10:20:32+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7168 Translation, validation, and first application of the Greek version of an irritable bowel syndrome severity scoring system 2024-03-20T12:22:21+02:00 Nikolaos Dimzas docdietmail@gmail.com Konstantinos Argyriou docdietmail@gmail.com Maria Zachou docdietmail@gmail.com Arezina Kasti docdietmail@gmail.com Konstantinos Petsis docdietmail@gmail.com Sophia Lambrinou docdietmail@gmail.com Aikaterini Tsolaki docdietmail@gmail.com Petros S. Potamianos docdietmail@gmail.com Andreas Kapsoritakis docdietmail@gmail.com <p><strong>Background</strong> The Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) is a selfadministered questionnaire that categorizes patients according to symptom severity. We aimed totranslate and adapt the English IBS-SSS, validate the Greek version, and detect factors predictive of IBS severity.</p> <p><strong>Methods</strong> The original English version was obtained from the Rome Foundation, and the final Greek version arose through a process of translation, comprehensibility evaluation and backtranslation. The 141 participants enlisted in the study were enrolled from 2 tertiary hospitals and were divided into 2 groups (98 patients and 43 healthy volunteers). We evaluated the questionnaire properties based on COSMIN criteria.</p> <p><strong>Results</strong> The recruited patients reported either diarrhea-predominant (34.7%), constipationpredominant (28.6%), or mixed subtype (36.7%) IBS. No significant variations were found regarding the frequency and intensity of abdominal pain and flatulence among the 3 IBS subtypes. Severity scores among healthy volunteers were significantly lower compared to IBS patients, irrespective of their disease subtype (P&lt;0.001). The Cronbach coefficient (α) was calculated at 0.953, suggesting high inter-item internal consistency. The intraclass correlation coefficient was calculated and found to be high, suggesting good responsiveness of the questionnaire. Two-way MANOVA evaluation showed that demographic variables (age, family status, body mass index [BMI], smoking, and alcohol consumption) in the Greek population affect the IBS-SSS score and syndrome severity.</p> <p><strong>Conclusions</strong> The Greek version of IBS-SSS is a reliable, valid and responsive tool for assessing Greek IBS patients’ symptom severity. Older age, smoking, alcohol use and higher BMI are indicative of greater symptom severity.</p> <p><strong>Keywords</strong> Irritable bowel syndrome, irritable bowel syndrome severity scoring system, severity, questionnaire, patient-reported outcomes</p> <p>Ann Gastroenterol 2024; 37 (2): 182-190</p> 2024-03-19T10:29:44+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7143 The prevalence and impact of psychiatric comorbidities on hospitalized inflammatory bowel disease patients in the United States: insights from the National Inpatient Sample from 2009-2018 2024-03-20T12:22:22+02:00 Marcella Pimpinelli mpimpinelli17@gmail.com Abhishek Bhurwal abhishek.bhurwal@gmail.com Sophia Pimpinelli sp2103@rwjms.rutgers.edu Hemant Mutneja hemantmutneja@gmail.com Carlos D. Minacapelli minacacd@rwjms.rutgers.edu B. Attar battar@cookcountyhhs.org Vikas Bansal drvikasbansal@gmail.com Lea Ann Chen leaann.chen@rutgers.edu Steven Brant steven.brant@rwjms.rutgers.edu Darren N. Seril serilda@rwjms.rutgers.edu <div class="page" title="Page 2"><strong>Background</strong> Patients with inflammatory bowel disease (IBD) are at increased risk of anxiety and mood disorders. This study examines the temporal trends and clinical impact of anxiety and mood disorder diagnoses in hospitalized IBD patients in the United States during a 10-year period.</div> <div class="page" title="Page 2">&nbsp;</div> <div class="page" title="Page 2"><strong>Methods</strong> Using the National Inpatient Sample from 2009-2018, all IBD-related discharges in adults were analyzed. Primary outcomes were the prevalence and temporal trends of mood disorder and anxiety diagnoses for IBD-related admissions. The impact of the psychiatric comorbidities on clinical outcomes was also evaluated.</div> <div class="page" title="Page 2">&nbsp;</div> <div class="page" title="Page 2"><strong>Results</strong> A total of 1,718,736 IBD-related discharged were identified. A diagnosis of anxiety or a mood disorder was found to have a prevalence of 16.44% and 18.97%, respectively, amongst IBDrelated admissions. The prevalence of anxiety disorders amongst hospitalized IBD patients increased significantly (from 12.13% to 20.26%), whereas the prevalence of mood disorders did not (17.46% and 18.9%). IBD admissions with psychiatric comorbidities had lower rates of IBD-related complications or mortality during hospitalization compared to IBD admissions without comorbid psychiatric diagnoses. This population, however, was more likely to experience certain comorbidities such as Clostridioides difficile, pneumonia, and venous thromboembolism, as well as a longer hospitalization.</div> <div class="page" title="Page 2">&nbsp;</div> <div class="page" title="Page 2"><strong>Conclusions</strong> The prevalence of comorbid anxiety among hospitalized IBD patients in the United States matches or exceeds the prevalence of anxiety in the general hospitalized population. Given its association with more in-hospital complications and a longer hospital stay, it is important to further understand how psychological screening and mental health services can improve the management of hospitalized IBD patients.</div> <div class="page" title="Page 2">&nbsp;</div> <div class="page" title="Page 2"><strong>Keywords</strong> Anxiety, mood disorder, inflammatory bowel disease, National Inpatient Sample, psychiatric comorbidities</div> <div class="page" title="Page 2">&nbsp;</div> <div class="page" title="Page 2">Ann Gastroenterol 2024; 37 (2): 192-198 <div class="layoutArea">&nbsp;</div> </div> 2024-03-19T10:35:05+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7179 Isolated nonspecific terminal ileitis: prevalence, clinical evolution and correlation with metachronous diagnosis of Crohn’s disease: a retrospective study and review of the literature 2024-03-20T12:22:22+02:00 Evgenia Koureta j.koureta@gmail.com Pantelis Karatzas Panteliskaratzas@gmail.com Maria Tampaki Dc_martam@hotmail.com Theodoros Voulgaris thvoulgaris87@gmail.com Efrosini Laoudi laoudif@gmail.com Stratigoula Sakellariou sakellarioustrat@yahoo.gr Ioanna Delladetsima jokadelladetsima@hotmail.com George Karamanolis georgekaramanolis@yahoo.co.uk Jiannis Vlachogiannakos jvlachog@hotmail.com George V. Papatheodoridis gepapath@med.uoa.gr <p><strong>Background</strong> The existing literature does not provide adequate guidance on the diagnosis and management of patients with nonspecific terminal ileitis, while data regarding the percentage of patients who ultimately develop Crohn’s disease (CD) are scarce. We evaluated the prevalence and natural course of nonspecific terminal ileitis in patients who underwent colonoscopy during a 11-year period.</p> <p><strong>Methods</strong> All patients with endoscopic findings of terminal ileitis and nonspecific histological findings were included. Exclusion criteria were a clinical history of CD or any other disease that can cause terminal ileitis, or a recent history of using drugs implicated in lesions of the terminal ileum.</p> <p><strong>Results</strong> From 5353 colonoscopies, 92 patients with nonspecific terminal ileitis were identified (prevalence: 1.7%). Among these patients, 56 (61%) had available follow up for ≥6 months after the initial endoscopy. Main indications for endoscopy were chronic diarrhea (37.5%), screening endoscopy (23%), and abdominal pain (20%). Sixteen (29%) patients received medical treatment, while recession of symptoms was recorded in 19 of 43 symptomatic patients (44.1%). Twenty-three (41%) of the 56 patients underwent a second endoscopy and 15 (65.2%) cases had persistent endoscopic findings. Eleven (19.6%) of the 56 patients were eventually diagnosed with CD. The probability of CD diagnosis was significantly higher in patients with persistent symptoms (P=0.002) and endoscopic findings at follow up (P=0.038).</p> <p><strong>Conclusions</strong> Nonspecific terminal ileitis generally has a benign clinical course. However, patients with persistent symptoms and endoscopic lesions are at increased risk for subsequent development of CD.</p> <p><strong>Keywords</strong> Nonspecific terminal ileitis, Crohn’s disease, colonoscopy</p> <p>Ann Gastroenterol 2024; 37 (2): 199-205</p> 2024-03-19T10:49:57+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7235 Demographics, distance to gastrointestinal specialists, and social deprivation are associated with advanced stage of gastrointestinal cancer diagnosis 2024-03-20T12:22:22+02:00 Shria Kumar shriakumar@med.miami.edu Saltenat Moghaddam sxm537@med.miami.edu Darius E. Chyou dxc950@med.miami.edu Ibrahim Soumare ibrahim.soumare@stcloudstate.edu Daniel A. Sussman dsussman@med.miami.edu <p><strong>Background</strong> Gastrointestinal (GI) luminal cancers can be detected at early stages by endoscopic procedures. Place-based factors, such as social deprivation and distance to specialist care, are under-investigated with regard to the stage of diagnosis.</p> <p><strong>Methods</strong> This was a retrospective cohort study among persons ≥18 years of age in the Florida Cancer Data System, a population-based cancer incidence registry. We included persons diagnosed with esophageal cancer, gastric canceror colorectal cancer, with at least 1 measure of geographic location during the period January 1, 1981, to December 31, 2016. Multivariate multinomial logistic regression was used to identify factors associated with the stage of diagnosis, including social deprivation and proximity to GI care.</p> <p><strong>Results</strong> Among 379,054 persons, the median age was 71 years, and 54% were male. Distant stage disease was significantly less likely than local stage in those of non-Hispanic/Latino ethnicity (odds ratio [OR] 0.92, 95% confidence interval [CI] 0.89-0.94, P&lt;0.001). Distant disease was more likely in African Americans (OR 1.30, 95%CI 1.26-1.34) and Asians (OR 1.41, 95%CI 1.27-1.56, P&lt;0.001), with each 5-min increase in travel time to specialists, (OR 1.02, 95%CI 1.01-1.02, P&lt;0.001), and with each 10-point increase in Social Deprivation Index (OR 1.01, 95%CI 1.01-1.02, P&lt;0.001).</p> <p><strong>Conclusions</strong> A greater distance from care and living in areas with increased deprivation are associated with an advanced stage of diagnosis and should be recipients of policy-driven efforts to improve access to care. That the strongest risk factors include minority race and ethnicity underlines the complexity of healthcare disparities.</p> <p><strong>Keywords</strong> Gastrointestinal cancer, disparities, access to care</p> <p>Ann Gastroenterol 2024; 37 (2): 206-214</p> 2024-03-19T10:58:16+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7171 Fibrin glue and coats compromise the integrity of colonic anastomosis: an experimental trial on rats 2024-03-20T12:22:22+02:00 Nikolaos Voloudakis nickvolou@gmail.com Ioannis Koutelidakis iokoutel@gmail.com Emmanouil Christoforidis emmch@auth.gr Stefanos Atmatzidis atmatzidis.stef@gmail.com Georgia Kotoreni georgiakot@hotmail.gr Basilios Papaziogas nickvolou@gmail.com Dimitrios Schizas dschizas@hotmail.com Christos Zavos nickvolou@gmail.com Apostolos Papalois apapalois@elpen.gr Grigorios Chatzimavroudis gchatzimav@yahoo.gr <p><strong>Background</strong> Anastomotic leak remains a dreaded complication in colorectal surgery. Identifying optimal techniques that minimize its incidence is an active area of investigation. The aim of this experimental study was to evaluate the effect of commonly used hemostatic products on the integrity of colonic anastomoses.</p> <p><strong>Methods</strong> Male Wistar rats were randomized into 4 groups. In the control group (A), the anastomosis was performed using the standard hand-sewn technique in the ascending colon. In group B the hand-sewn technique was reinforced with a collagen–fibrinogen patch, in group C with fibrin glue, and in group D with a polyethylene glycol (PEG)-coated oxidized cellulose patch. On the 7th postoperative day, anastomotic bursting pressure measurements were obtained. A specimen surrounding the anastomosis was retrieved for histopathologic evaluation.</p> <p><strong>Results</strong> Of the 19 rats, 17 survived and 15 were included in the analysis (5 in each of groups A, B and C). Testing in group D was discontinued following adverse events in the preliminary experiments. The mean bursting pressure of the anastomosis was significantly higher in the control group (A: 221±19.41 mmHg, B: 151±14.42 mmHg, and C: 112±13.57 mmHg; P=0.001). Anastomotic healing parameters were not different between groups.</p> <p><strong>Conclusions</strong> Although experimental data support the use of sealants in defective anastomoses, in this study the reinforcement of colonic anastomosis with fibrin or oxidized cellulose-PEG sealants did not improve either bursting pressure values or anastomotic healing. More data from robust anastomoses of animals and humans are needed before sealing becomes common clinical practice in colorectal surgery.</p> <p><strong>Keywords</strong> Anastomotic bursting pressure, colonic anastomosis, anastomotic leak, fibrin glue, collagen patch</p> <p>Ann Gastroenterol 2024; 37 (2): 216-224</p> 2024-03-19T11:04:36+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7176 Performance and safety of percutaneous cholangioscopy: a systematic review and meta-analysis 2024-03-20T12:22:22+02:00 Apostolis Papaefthymiou appapaef@hotmail.com Paraskevas Gkolfakis pgolfakis@gmail.com Kirill Basiliya kirill.v.basiliya@gmail.com Antonio Facciorusso antonio.facciorusso@virgilio.it Daryl Ramai Daryl.Ramai@hsc.utah.edu Christian Gerges christian.gerges@evk-duesseldorf.de Georgios Tziatzios g_tziatzios@yahoo.gr Simon Phillpotts simon.phillpotts@nhs.net George J. Webster george.webster1@nhs.net <p><strong>Background</strong> Percutaneous cholangioscopy (PerC) offers an alternative for patients with an inaccessible biliary tree. This systematic review and meta-analysis aimed to evaluate the performance of this technique.</p> <p><strong>Methods</strong> A search in Medline, Cochrane and ClinicalTrials.gov databases was performed for studies assessing PerC up to October 2022. The primary outcome was diagnostic success, defined as successful stone identification or stricture workup. Secondary outcomes included therapeutic success (stone extraction, stenting) and complication rate. A subgroup analysis compared previous-generation and modern cholangioscopes. We performed meta-analyses using a randomeffects model and the results were reported as percentages with 95% confidence interval (CI).</p> <p><strong>Results</strong> Fourteen studies (682 patients) were eligible for analysis. The rate of diagnostic success was 98.7% (95%CI 97.6-99.8%; I2=31.19%) and therapeutic success was 88.6% (95%CI 82.8- 94.3%; I2=74.92%). Adverse events were recorded in 17.1% (95%CI 10.7-23.5%; I2=77.56%), of which 15.9% (95%CI 9.8-21.9%; I2=75.98%) were minor and 0.6% (95%CI 0.1-1.2%; I2=0%) major. The Spyglass system showed null heterogeneity for all outcomes; compared with older-generation endoscopes it offered comparable diagnostic success, but yielded significantly superior therapeutic success (96.1%, 95%CI 90-100%; I2=0% vs. 86.4%, 95%CI 79.2-93.6%; I2=81.41%; P=0.02].</p> <p><strong>Conclusion</strong> PerC, especially using currently available cholangioscopes, is associated with high diagnostic and therapeutic success.</p> <p><strong>Keywords</strong> Cholangioscopy, percutaneous cholangioscopy, surgically altered anatomy</p> <p>Ann Gastroenterol 2024; 37 (2): 225-234</p> 2024-03-19T11:09:59+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7242 Endoscopic ultrasound-guided lumen-apposing metal stent with or without coaxial plastic stent for pancreatic fluid collections: a systematic review and meta-analysis comparing safety and efficacy 2024-03-20T12:22:23+02:00 Harishankar Gopakumar hgopakumarmd@gmail.com Vakya Revanur vakyarevanur@gmail.com Rajanikanth Kandula drrkreddy80@gmail.com Srinivas R. Puli srinivas.puli@osfhealthcare.org <p><strong>Background</strong> Endoscopic ultrasound (EUS)-guided lumen-apposing metal stents (LAMS) are preferred for draining symptomatic large pancreatic fluid collections (PFCs). A concurrent coaxial double-pigtail plastic stent (DPPS) is proposed to reduce adverse events associated with LAMS. We aimed to perform a comparative outcome analysis of LAMS with or without DPPS for PFCs.</p> <p><strong>Methods</strong> Electronic databases from January 2005 through July 2023 were searched for studies comparing the use of LAMS with or without DPPS for PFCs. Pooled proportions were calculated using fixed (inverse variance) and random-effects (DerSimonian-Laird) models.</p> <p><strong>Results</strong> After reviewing 1780 studies, we extracted data from 6 studies comprising 348 patients. The weighted odds of overall technical success, using LAMS plus DPPS compared to LAMS alone, were 0.53 (95% confidence interval [CI] 0.15-1.83), and the odds of clinical success were 1.10 (95%CI 0.59-2.05). The weighted odds of total adverse events with LAMS compared to LAMS plus DPPS were 2.21 (95%CI 1.37-3.59). Analysis of individual adverse events showed that the odds of stent occlusion when LAMS alone was used compared to LAMS plus DPPS was 2.36 (95%CI 1.12-4.98). The odds of bleeding were 1.84 (95%CI 0.77-4.38), and the odds of stent migration 0.95 (95%CI 0.40-2.23).</p> <p><strong>Conclusions</strong> EUS-guided LAMS placement is the current standard of care for managing symptomatic large PFCs. Concurrent use of coaxial DPPS can mitigate the overall adverse events observed with LAMS, while maintaining similar technical and clinical success.</p> <p><strong>Keywords</strong> Pancreatic fluid collections, walled-off pancreatic necrosis, lumen-apposing metal stent, double pigtail plastic stents, endoscopic ultrasound</p> <p>Ann Gastroenterol 2024; 37 (2): 242-250</p> 2024-03-19T11:15:32+02:00 ##submission.copyrightStatement## http://annalsgastro.gr/index.php/annalsgastro/article/view/7206 Peroral endoscopic myotomy for the management of symptomatic cricopharyngeal bar (C-POEM): a case series and video demonstration 2024-03-20T12:22:23+02:00 Benjamin Norton benjamin.norton@nhs.net Apostolis Papaefthymiou a.papaefthymiou@nhs.net Andrea Telese telesea@ccf.org Nasar Aslam nasar.aslam@nhs.net Charles Murray murrayc7@ccf.org Rehan Haidry haidryr@ccf.org <p><strong>Background</strong> A cricopharyngeal bar refers to a radiological description of a prominent cricopharyngeal muscle. While these may be incidental, they can lead to significant oropharyngeal dysphagia due to incoordination of the upper esophageal sphincter and true luminal narrowing. Various treatments have been used for the management of cricopharyngeal bar, including botulinum toxin injection, dilation, and surgical myotomy. Cricopharyngeal peroral endoscopic myotomy (C-POEM) is a novel procedure that uses the principles of “third-space” endoscopy to treat symptomatic cricopharyngeal bar.</p> <p><strong>Methods</strong> We report a retrospective case series of 5 patients referred with oropharyngeal dysphagia to 2 UK tertiary referral centers between 2022 and 2023 who subsequently underwent C-POEM. Technical success was defined as completion of all steps of the C-POEM procedure and clinical success as a reduction in the pre-treatment Dakkak and Bennett score to ≤1, or 0 if the pre-treatment score was 1.</p> <p><strong>Results</strong> C-POEM was associated with a technical success of 100% and clinical success of 100% over a median follow up of 2 months (interquartile range 1-8). There was 1 adverse event due to a small mucosal defect and associated leak on barium swallow, which was the result of difficult access during mucosal closure. This was managed conservatively with antibiotics. A step-by-step video demonstration of the procedure is provided.</p> <p><strong>Conclusion</strong> C-POEM offers an alternative upfront therapy for symptomatic cricopharyngeal bar, but should be undertaken by endoscopists with significant experience in third-space endoscopy in view of the difficulty of working within the hypopharynx.</p> <p><strong>Keywords</strong> Cricopharyngeal bar, peroral endoscopic myotomy, cricopharyngeal dysfunction, therapeutic endoscopy</p> <p>Ann Gastroenterol 2024; 37 (2): 251-254</p> 2024-03-19T11:20:04+02:00 ##submission.copyrightStatement##